Laparoscopic partial nephrectomy
Philip T Zhao, Lee Richstone, Louis R Kavoussi, Philip T Zhao, Lee Richstone, Louis R Kavoussi
Abstract
Laparoscopic partial nephrectomy (LPN) compares favorably to traditional open nephron-sparing surgery (NSS) in terms of oncologic and surgical principles for kidney tumors. Studies have shown the modality to be feasible with similar oncologic efficacy and superior renal functional outcomes compared with laparoscopic radical nephrectomy (LRN) for tumors. The main advantages of LPN include marked improvements in estimated blood loss, decreased surgical site pain, shorter postoperative convalescence, better cosmesis, and nephron preservation. This review article evaluates the literature regarding LPN and discusses the main steps of the operation, the perioperative workup and management, surgical complications, and its role in the surgical management of kidney masses.
Keywords: Kidney cancer; Kidney mass; Laparoscopic partial nephrectomy; Laparoscopy; Nephron-sparing surgery.
Copyright © 2016 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.
Source: PubMed
Upcoming Clinical Trials
-
Nicholas ButowskiSiren BiotechnologyNot yet recruitingGlioma | Brain Neoplasm | Recurrent High-Grade GliomasUnited States
-
State University of New York at BuffaloNot yet recruitingPatient EngagementUnited States
-
Poitiers University HospitalNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSickle Cell Disease | Vaso-occlusive Crisis
-
University of California, IrvineRecruitingBrain Cancer | CNS Cancer | Nervous System Cancer | Brain Cancer MetastaticUnited States
-
Qualia Life SciencesRecruiting
-
Guangdong Raynovent Biotech Co., LtdNot yet recruiting
-
The Hong Kong Polytechnic UniversityWu Jieh Yee Charitable FoundationRecruitingAdults | Low Vision Digital Assistance | Visual ImpairmentsHong Kong
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingPancreatic Ductal Adenocarcinoma (PDAC)
-
Sun Yat-sen UniversityNot yet recruitingSmoking Cessation | AI Agent | Early-Stage Cancer
-
Affiliated Hospital of Nantong UniversityNot yet recruiting
-
AIMEDBIOBoehringer IngelheimNot yet recruitingSolid TumoursFrance, Japan, South Korea, United States, Australia